Literature DB >> 10470336

Antimalarial drug resistance and mortality in falciparum malaria.

N White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10470336     DOI： 10.1046/j.1365-3156.1999.00435.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


× No keyword cloud information.
  9 in total

1.  In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.

Authors:  Kasia Stepniewska; Walter R J Taylor; Mayfong Mayxay; Ric Price; Frank Smithuis; Jean-Paul Guthmann; Karen Barnes; Hla Yin Myint; Martin Adjuik; Piero Olliaro; Sasithon Pukrittayakamee; Sornchai Looareesuwan; Tran Tinh Hien; Jeremy Farrar; François Nosten; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.

Authors:  Daniel J Kyabayinze; Charles Karamagi; Moses Kiggundu; Moses R Kamya; Fred Wabwire-Mangen; Fred Kironde; Ambrose Talisuna
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

3.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

4.  Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.

Authors:  Nahla B Gadalla; Salah Eldin Elzaki; Ebtihal Mukhtar; David C Warhurst; Badria El-Sayed; Colin J Sutherland
Journal:  Malar J       Date:  2010-03-12       Impact factor: 2.979

5.  Identification and expression analysis of ABC genes in Plasmodium yoelii and P. berghei.

Authors:  A C Szeto; J Pérez-Rosado; I Ferrer-Rodríguez; J Vega; C Torruella-Thillet; A E Serrano
Journal:  Parasitol Res       Date:  2003-10-17       Impact factor: 2.289

Review 6.  The niche reduction approach: an opportunity for optimal control of infectious diseases in low-income countries?

Authors:  Benjamin Roche; Hélène Broutin; Marc Choisy; Sylvain Godreuil; Guillaume Constantin de Magny; Yann Chevaleyre; Jean-Daniel Zucker; Romulus Breban; Bernard Cazelles; Frédéric Simard
Journal:  BMC Public Health       Date:  2014-07-25       Impact factor: 3.295

7.  Evolution of malaria mortality and morbidity after the emergence of chloroquine resistance in Niakhar, Senegal.

Authors:  Aline Munier; Aldiouma Diallo; Adama Marra; Michel Cot; Pascal Arduin; Ousmane Ndiaye; Balla Mbacké Mboup; Barnabé Gning; Jean-Philippe Chippaux
Journal:  Malar J       Date:  2009-11-27       Impact factor: 2.979

8.  Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.

Authors:  M F Gomes; M A Faiz; J O Gyapong; M Warsame; T Agbenyega; A Babiker; F Baiden; E B Yunus; F Binka; C Clerk; P Folb; R Hassan; M A Hossain; O Kimbute; A Kitua; S Krishna; C Makasi; N Mensah; Z Mrango; P Olliaro; R Peto; T J Peto; M R Rahman; I Ribeiro; R Samad; N J White
Journal:  Lancet       Date:  2008-12-06       Impact factor: 79.321

9.  Compliance With Referral Advice After Treatment With Prereferral Rectal Artesunate: A Study in 3 Sub-Saharan African Countries.

Authors:  Mohamadou Siribié; IkeOluwapo O Ajayi; Jesca Nsungwa-Sabiiti; Armande K Sanou; Ayodele S Jegede; Chinenye Afonne; Catherine O Falade; Melba Gomes
Journal:  Clin Infect Dis       Date:  2016-12-15       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.